1. |
From the Editor |
|
Inpharma Weekly,
Volume &NA;,
Issue 962,
1994,
Page 2-2
&NA;,
Preview
|
PDF (789KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
2. |
Antioxidants every day - keeping heart disease at bay |
|
Inpharma Weekly,
Volume &NA;,
Issue 962,
1994,
Page 3-4
Jill Stein,
Preview
|
PDF (1524KB)
|
|
摘要:
Daily intake of the antioxidant vitamin E is associated with a delay in the progression of coronary atherosclerosis after CABG and a reduction in the risk of restenosis post-PTCA, according to the findings of 2 new studies. Beneficial effects in slowing plaque build-up were noted even in patients not receiving cholesterol-lowering drugs. These encouraging results are further supported by a study reporting that low dietary vitamin E intake is related to an increased risk of CHD-related death in patients with no prior evidence of CHD who were controlled for common coronary risk factors. Larger studies are warranted to confirm the clinical benefit and optimal supplementary dose of this vitamin. The trial results were presented at the Second International Conference on Antioxidant Vitamins and Betacarotene in Disease Prevention [Berlin, Germany; October 1994].
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
3. |
Tuberculosismultidrug resistance limits adequate regimens |
|
Inpharma Weekly,
Volume &NA;,
Issue 962,
1994,
Page 4-4
&NA;,
Preview
|
PDF (755KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
4. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 962,
1994,
Page 5-5
&NA;,
Preview
|
PDF (748KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
5. |
Postop nausea/vomiting a costly event |
|
Inpharma Weekly,
Volume &NA;,
Issue 962,
1994,
Page 6-6
&NA;,
Preview
|
PDF (767KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
6. |
Colfosceril palmitate cost saving in neonatal RDS |
|
Inpharma Weekly,
Volume &NA;,
Issue 962,
1994,
Page 7-7
&NA;,
Preview
|
PDF (762KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
7. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 962,
1994,
Page 8-8
&NA;,
Preview
|
PDF (723KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
8. |
Herpes virus infections - the future holds new options for treatment |
|
Inpharma Weekly,
Volume &NA;,
Issue 962,
1994,
Page 9-10
Robert Short,
Preview
|
PDF (1579KB)
|
|
摘要:
The monopoly held by aciclovir in the treatment of herpes infections is about to crumble. The first challenge comes from famciclovir [Famvir®; SmithKline Beecham], which was recently launched for the treatment of herpes zoster. Valaciclovir [ValtrexTM; Wellcome; preregistration] looks set to follow shortly, and several other agents are under development. SmithKline Beecham is also making good progress with its gD2t vaccine, which is about to enter phase III trials [see boxed text]. The current state of play in herpes-related therapy was discussed during several presentations at the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy [Orlando, US; October 1994].
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
9. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 962,
1994,
Page 10-10
&NA;,
Preview
|
PDF (761KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
10. |
New thrombolytic may increase options for stroke treatment |
|
Inpharma Weekly,
Volume &NA;,
Issue 962,
1994,
Page 11-11
&NA;,
Preview
|
PDF (742KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|